Quest Resource (QRHC) Director Reports DSU Grant and Holdings
Rhea-AI Filing Summary
Nolan Stephen A, a director of Quest Resource Holding Corp (QRHC), reported insider transactions on Form 4 dated 08/31/2025. The filing shows an acquisition of 1,871 deferred stock units (DSUs) at an effective price of $1.87 per share, granted under the Issuer's 2024 Incentive Compensation Plan; the underlying common shares for those DSUs will be issued upon the reporting person's separation from service. The report discloses total beneficial holdings that include 63,657 DSUs from the 2012 plan, 13,823 DSUs from the 2024 plan, 20,000 restricted stock units (RSUs) scheduled to fully vest on August 13, 2026, and 92,585 shares of common stock (including 5,000 held jointly with spouse).
Positive
- Grant recorded: Acquisition of 1,871 DSUs at $1.87 under the 2024 Incentive Compensation Plan
- Detailed holdings disclosed: Includes 63,657 DSUs (2012 plan), 13,823 DSUs (2024 plan), 20,000 RSUs vesting 08/13/2026, and 92,585 common shares (5,000 jointly held)
Negative
- None.
Insights
TL;DR: Director received equity compensation in the form of DSUs and holds RSUs and common shares; transaction is compensation-related, not an open-market trade.
The Form 4 documents a grant-based acquisition of 1,871 DSUs at $1.87 on 08/31/2025 under the 2024 Incentive Compensation Plan. The filing clarifies these are deferred units whose underlying shares will be issued upon separation from service. Reported beneficial ownership combines multiple plan grants and outstanding shares, including 20,000 RSUs vesting on 08/13/2026 and 92,585 common shares (5,000 jointly held). From an analytical perspective, this is a routine insider compensation disclosure rather than a cash purchase or sale, and therefore primarily informs schedule and magnitude of equity that could convert to common stock in the future.
TL;DR: The filing reflects standard director compensation via deferred equity grants with specified vesting/issuance conditions.
The report specifies DSUs granted under the 2012 and 2024 Incentive Compensation Plans and RSUs with a stated vest date of August 13, 2026. The DSUs' underlying shares will be issued upon separation from service, indicating deferred compensation treatment. The signature by an attorney-in-fact is present and the filing lists the reporting person's status as a director. No sales, option exercises, or derivative transactions are reported in Table II. This is a routine disclosure relevant to shareholder dilution timing and governance transparency.